Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CLRO and 80,000+ other tickers.
See exactly how CLRO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CLRO and 80,000+ other tickers.
ClearOne, Inc., established in 1983 and headquartered in Salt Lake City, Utah, specializes in the design, development, and sale of advanced communication solutions. The company provides a comprehensive suite of conferencing, collaboration, and network streaming products for both audio and visual interactions, serving markets across the United States and internationally. Its diverse portfolio includes a wide array of audio conferencing technologies. These range from sophisticated professional audio conferencing and sound reinforcement systems tailored for large organizations in sectors like…
NEW YORK, July 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating ClearOne, Inc. (NYSE: CLRO ) related to its merger with Cortigent, Inc. Upon completion of the proposed transaction, ClearOne shareholders will own approximately 12.7% to 14.4% of the outstanding equity in the combined company.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ClearOne, Inc. (NYSE: CLRO) and Cortigent, Inc. Upon closing of the Proposed Transaction, ClearOne shareholders will own 12.7% to 14.4% of the outstanding equity in the combined company.Halper Sadeh encourages ClearOne shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or z.
Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company's name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and "CRGT" Cortigent is a leading developer of brain computer interface ("BCI") devices based on precision neurostimulation technology ALAMEDA, Calif.
SALT LAKE CITY--(BUSINESS WIRE)--ClearOne, Inc. (Nasdaq: CLRO) (“ClearOne”) announced today that it has entered into a definitive agreement and plan of merger (the “Agreement”) among its wholly-owned subsidiary (“MergerSub”), Vivani Medical, Inc. (Nasdaq: VANI; “Vivani”), and Cortigent, Inc. (“Cortigent”), a wholly-owned subsidiary of Vivani, pursuant to which Cortigent will become a wholly-owned subsidiary of ClearOne (the “Transaction”) upon consummation. In connection with the Transaction, C.
Airgain (NASDAQ: AIRG - Get Free Report) and ClearOne (NASDAQ: CLRO - Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 52.8% of Airgain